Skip to main content
NovMetaPharma Co., Ltd. logo

NovMetaPharma Co., Ltd. — Investor Relations & Filings

Ticker · 229500 ISIN · KR7229500004 KO Manufacturing
Open in API
Filings indexed 308 across all filing types
Latest filing 2025-12-18 Capital/Financing Update
Country KR South Korea
Listing KO 229500

About NovMetaPharma Co., Ltd.

http://www.novmeta.com/

NovMetaPharma Co., Ltd. is a biopharmaceutical company specializing in the research and development of first-in-class drugs with differentiated mechanisms. The company focuses on creating novel therapeutics for metabolic and fibrotic diseases, addressing significant unmet medical needs. Its main pipeline includes drug candidates for type 2 diabetes (NovDB2), obesity (NovOB), chronic kidney disease (NovRD), and fibrosis (NovFS). The company's lead assets in clinical development are Cyclo-Z and CHP. NovMetaPharma aims to develop innovative treatments by leveraging its core research teams and efficient development systems to target the root causes of these complex conditions.

Recent filings

Filing Released Lang Actions
소액공모실적보고서
Capital/Financing Update Classification · 95% confidence The document is a '소액공모실적보고서' (Report on the Results of a Small-Scale Public Offering) filed by NovMetaPharma. This document details the results of a capital raise (issuance of new shares), including the subscription status, allocation, and use of proceeds. In the context of financial filings, reports detailing capital changes, share issuance, and the results of public offerings are classified under 'Share Issue/Capital Change' (SHA).
2025-12-18 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is titled '기업설명회(IR) 개최 결과' which translates to 'Investor Relations (IR) Meeting Results'. It details the date, time, location, attendees, main contents (company status, management outlook, Q&A), and confirmation by regulatory bodies. The document is a summary of an investor presentation event rather than the presentation slides or detailed financial data itself. It is a report on the occurrence and results of an IR meeting, fitting the category of Investor Presentation (IP). The document length is short but contains substantive event details, not just an announcement of a report publication, so it is not RPA. Therefore, the classification is Investor Presentation (IP).
2025-11-06 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is an announcement of an upcoming Investor Presentation (IR) event scheduled for November 6, 2025. It details the event's date, time, location, target audience, purpose, and agenda, but does not contain any financial data or report content itself. The document is short (988 characters) and serves to inform about the event rather than provide the presentation or report. Therefore, it fits the category of Investor Presentation (IP) announcement rather than the actual presentation or report.
2025-10-21 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) meeting held by NovMetaPharma. It lists the date, location, attendees, and agenda items of the meeting, and provides a link to where the actual IR materials are posted. Since it is a brief notification of an event and its outcome rather than the full presentation deck itself, it falls under the category of a regulatory announcement regarding corporate activities.
2025-05-15 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by NovMetaPharma. It details the patent name, content, and utilization plan. Since it is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2025-05-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal notice announcing an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location (online), target audience, and purpose of the meeting. Since this is an announcement of an event rather than the presentation materials themselves or a financial report, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' (RNS) category as it is a standard corporate disclosure notice in the Korean market.
2025-04-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.